Envista Holdings Corporation Common Stock (NVST)
Stock · NYSE · Health Care
$22.91as of 10/16/2026
Price chart
Active signals
NVST Signal Track Record
How signals performed across all stocks →What NVST's price did in the 20 trading sessions after each past signal, compared with any 20-session window over the same period.
| Signal | Times | Median 20-session return | Higher after 20 sessions | Last signal |
|---|---|---|---|---|
| Volume Spike | 33 | -2.6% | 39% | September 8, 2026 |
| Bollinger Band Breakdown | 23 | -3.9% | 35% | September 10, 2026 |
| Bollinger Band Breakout | 21 | +0.2% | 52% | July 29, 2026 |
| 200-Day Moving Average TouchActive now | 17 | +3.2% | 71% | September 11, 2026 |
| Any 20-session window (baseline) | -1.0% | 46% |
Computed by MarketWall from daily closing prices since May 18, 2022. Returns are close-to-close and don't include dividends. Past results describe what happened before; they are not a forecast and not investment advice.
About NVST
Envista Holdings Corporation, together with its subsidiaries, develops, manufactures, markets, and sells dental products in the United States, China, and internationally. The company operates in two segments, Specialty Products & Technologies, and Equipment & Consumables. The Specialty Products & Technologies segment offers dental implant systems, guided surgery systems, biomaterials, and prefabricated and custom-bui…
- Sector
- Health Care
- Industry
- Medical/Dental Instruments
- Employees
- 12,000
- Website
- envistaco.com/en
Fundamentals
- 1-day range
- $22.5$23.52
- Market cap
- $4.46B
- P/E (trailing)
- 39.56
- P/E (forward)
- 14.12
- EPS (trailing)
- $0.58
- Dividend yield
- —
- Beta
- 0.95
- Avg. volume
- 2.76M
How Envista Holdings Corporation Common Stock Makes Money
Where the revenue actually goes — FY2025 annual results
Source: 10-K filed Feb 12, 2026 · via SEC EDGAR / Finnhub
Forecasts
13 analyst ratings
Envista Holdings Corporation Common Stock Competitors
Chosen by industry and closest market cap.
- NVSTEnvista Holdings Corporation Common Stock$22.9▼ 2.55%Market cap $4.46BP/E 39.56$18.77$30.42
- IRTCiRhythm Holdings Inc. Common Stock$108.66▼ 0.63%Market cap $4.21BP/E —$100.7$212
- ICUIICU Medical Inc. Common Stock$162.99▼ 2.54%Market cap $4.16BP/E 139.19$113.37$192.85
- HAEHaemonetics Corporation Common Stock$118.28▼ 2.48%Market cap $3.86BP/E 56.08$48.17$121.19
- MMEDMiniMed Group Inc. Common Stock$17.49▼ 2.83%Market cap $5.17BP/E —$10.65$24.43
- MMSIMerit Medical Systems Inc. Common Stock$89.2▼ 0.41%Market cap $5.24BP/E 36.33$59.74$94.75
- STVNStevanato Group S.p.A. Ordinary Shares$18.9▼ 1.82%Market cap $6.14BP/E 34.82$12.89$27.99
| Symbol | Market cap | P/E ratio | Price | 1D | 52-week range |
|---|---|---|---|---|---|
| NVST Envista Holdings Corporation Common Stock | $4.46B | 39.56 | $22.9 | ▼ 2.55% | $18.77$30.42 |
| IRTC iRhythm Holdings Inc. Common Stock | $4.21B | — | $108.66 | ▼ 0.63% | $100.7$212 |
| ICUI ICU Medical Inc. Common Stock | $4.16B | 139.19 | $162.99 | ▼ 2.54% | $113.37$192.85 |
| HAE Haemonetics Corporation Common Stock | $3.86B | 56.08 | $118.28 | ▼ 2.48% | $48.17$121.19 |
| MMED MiniMed Group Inc. Common Stock | $5.17B | — | $17.49 | ▼ 2.83% | $10.65$24.43 |
| MMSI Merit Medical Systems Inc. Common Stock | $5.24B | 36.33 | $89.2 | ▼ 0.41% | $59.74$94.75 |
| STVN Stevanato Group S.p.A. Ordinary Shares | $6.14B | 34.82 | $18.9 | ▼ 1.82% | $12.89$27.99 |
P/E shows — for peers not currently carrying a live signal of their own.
Latest news
- This Align Technology Analyst Is No Longer Bullish; Here Are Top 5 Downgrades For Thursdaybenzinga · 10/15/2026
- Piper Sandler Maintains Neutral on Envista Holdings, Lowers Price Target to $26Benzinga · 10/9/2026
- 3 Cash-Producing Stocks We Find RiskyYahoo · 10/8/2026
- Envista Schedules Third Quarter 2026 Earnings CallYahoo · 10/6/2026
- 1 of Wall Street’s Favorite Stocks to Keep an Eye On and 2 We IgnoreYahoo · 10/2/2026
- Leaner Operations and Improving Dental Demand Position Envista Holdings Corp. (NVST) for Multi-Year GrowthYahoo · 10/1/2026
- Dental Equipment & Technology Stocks Q2 Earnings Review: Envista (NYSE:NVST) ShinesYahoo · 9/30/2026
- BMO Capital Maintains Market Perform on Envista Holdings, Lowers Price Target to $26Benzinga · 9/28/2026
- New Strong Buy Stocks for September 28thYahoo · 9/28/2026
Insider Activity
Insider Actions →- Eric D. Hammes · August 25, 2026 · Tax Withholding10.9K @ $27.47
- Veronica Acurio · August 25, 2026 · Tax Withholding7.7K @ $27.47
- Stefan Nilsson · August 25, 2026 · Tax Withholding804 @ $27.47
- Robert Befidi · August 25, 2026 · Tax Withholding5.1K @ $27.47
- Mischa Reis · August 20, 2026 · Sale8.0K @ $27.5
- Paul A. Keel · August 18, 2026 · Grant159.9K
- Paul A. Keel · August 18, 2026 · Grant179.7K
- Eric D. Hammes · August 18, 2026 · Grant48.0K
- Paul A. Keel · May 25, 2026 · Tax Withholding12.8K @ $23.43
- James Andrew Pierce · May 19, 2026 · Grant9.3K
- Wendy Carruthers · May 19, 2026 · Grant9.3K
- Vivek Jain · May 19, 2026 · Grant9.3K
- R. Scott Huennekens · May 19, 2026 · Grant12.6K
- Kieran Gallahue · May 19, 2026 · Grant9.3K
- Daniel Raskas · May 19, 2026 · Grant9.3K
Institutional Ownership
March 31, 2026
- Total shares held
- 166.30M
- Total value held
- $4.15B
- Institutional holders
- 377
- Unknown17.85M
- Unknown10.86M
- Unknown9.78M
- Unknown8.79M
- Unknown7.32M
- Unknown6.89M
- Unknown5.36M
- Unknown5.23M
- Unknown5.03M
- Unknown4.58M
See the full, filterable feed with live charts on the MarketWall dashboard.
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 10, 2026
Piper Sandler cuts Envista price target to $26, maintains Neutral
Piper Sandler recently lowered its price target for Envista Holdings to $26 while keeping a Neutral stance. This move aligns with the stock's current trading level near its 52-week low of $18.77. The company has also scheduled its third-quarter 2026 earnings call, which will provide updated financial insights.
Piper Sandler cuts Envista price target to $26, maintains Neutral. Piper Sandler recently lowered its price target for Envista Holdings to $26 while keeping a Neutral stance. This move aligns with the stock's current trading level near its 52-week low of $18.77. The company has also scheduled its third-quarter 2026 earnings call, which will provide updated financial insights.